Clinical Trials Logo

Refractory Childhood Epilepsy clinical trials

View clinical trials related to Refractory Childhood Epilepsy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04172311 Recruiting - Clinical trials for Refractory Childhood Epilepsy

Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy

LEVEMAD
Start date: November 14, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

In this study, the efficacy of add-on modified Atkins diet will be compared with add-on Levetiracetam in children with refractory epilepsy in a randomized open label trial. The results will aid clinicians in deciding the treatment options when a child has been diagnosed to have refractory epilepsy.

NCT ID: NCT02556008 No longer available - Clinical trials for Refractory Childhood Epilepsy

Cannabidiol for Pediatric Epilepsy (Compassionate Use)

Start date: n/a
Phase: N/A
Study type: Expanded Access

This is an open-label observational study of pure CBD for the treatment for 25 children with intractable epilepsy. As pure CBD is not FDA approved, the investigators are conducting this study via the FDA expanded access mechanism on a compassionate use basis. The target patient population is children with severe refractory epilepsy who have exhausted all other reasonable avenues of treatment. These are patients for whom the risks of a relatively untested product are outweighed by the potential benefit. Using seizure-diaries maintained on a routine clinical basis, seizure frequency will be assessed four weeks prior to initiation of CBD, one month after CBD initiation, and at least every 3 months thereafter. CBD will be administered as an adjunct to all current anti-epileptic therapies.

NCT ID: NCT00836836 Completed - Clinical trials for Refractory Childhood Epilepsy

Modified Atkins Diet in Childhood Epilepsy

mAD
Start date: May 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Seizures are a frequent cause of morbidity in the pediatric age group. Uncontrolled seizures pose a variety of risks to children, including higher rates of mortality, developmental delay and/or regression, and cognitive impairment. The ketogenic diet is a well known treatment option for refractory epilepsy. However it is very restrictive and requires strict weighing of foods. The modified Atkins diet is a dietary therapy for intractable childhood epilepsy that was designed to be a less restrictive alternative to the traditional ketogenic diet. Early studies have demonstrated efficacy and safety.There are no randomized trials evaluating the efficacy of the modified Atkins diet in children with refractory epilepsy. Hence this study has been planned to investigate whether there are clear benefits in terms of seizure control in children with refractory epilepsy who are treated with the modified Atkins diet, versus controls.